An Evidence-Based Review of Fremanezumab for the Treatment of Migraine
Pain and Therapy - United States
doi 10.1007/s40122-020-00159-3
Full Text
Open PDFAbstract
Available in full text
Date
March 28, 2020
Authors
Publisher
Springer Science and Business Media LLC